Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sayah

Showing results (501-510 of 524) with videos related to

Pageof 53
Sort By:
American Journal of Respiratory Cell and Molecular Biology|October 25, 2019
Mitochondrial DNA Stimulates TLR9-Dependent Neutrophil Extracellular Trap Formation in Primary Graft DysfunctionBeñat Mallavia, Fengchun Liu, Emma Lefrançais, et al.
Cerebellum (London, England)|May 22, 2026
A Patient-Reported Outcome Measure of Communication Difficulties in Friedreich Ataxia: COMATAXMaresa Buchholz, Victoire Monier, Claire Ewenczyk, et al.
Annals of the American Thoracic Society|April 15, 2016
Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center ExperienceCatherine H Miele, Kristin Schwab, Rajeev Saggar, et al.
JAMA|March 29, 2012
Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trialHarry P Selker, Joni R Beshansky, Patricia R Sheehan, et al.
The American Journal of Cardiology|May 6, 2014
One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care] Trial)Harry P Selker, James E Udelson, Joseph M Massaro, et al.
Journal of Medicinal Chemistry|October 26, 2025
Discovery of ORIC-533, an Orally Bioavailable CD73 Inhibitor That Maintains Activity in High AMP Environments to Reverse Tumor ImmunosuppressionJared T Moore, Hiroyuki Kawai, Brian R Blank, et al.
JCI Insight|November 8, 2022
NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomesDaniel R Calabrese, Tasha Tsao, Mélia Magnen, et al.
Brain : a Journal of Neurology|March 26, 2015
Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's diseaseCaroline Moreau, Sayah Meguig, Jean-Christophe Corvol, et al.
The European Respiratory Journal|July 9, 2026
Lung Transplantation for Pulmonary Alveolar Proteinosis - a Retrospective International Multi-Center AnalysisStefan Schwarz, Helmut Prosch, Erdal Yekeler, et al.
The Lancet Regional Health. Europe|June 26, 2021
Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational studyEric Van Belle, Thibault Manigold, Adeline Piérache, et al.
Pageof 53

Showing results (501-510 of 524) with videos related to

Sort By:
Pageof 53
American Journal of Respiratory Cell and Molecular Biology|October 25, 2019
Mitochondrial DNA Stimulates TLR9-Dependent Neutrophil Extracellular Trap Formation in Primary Graft DysfunctionBeñat Mallavia, Fengchun Liu, Emma Lefrançais, et al.
Cerebellum (London, England)|May 22, 2026
A Patient-Reported Outcome Measure of Communication Difficulties in Friedreich Ataxia: COMATAXMaresa Buchholz, Victoire Monier, Claire Ewenczyk, et al.
Annals of the American Thoracic Society|April 15, 2016
Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center ExperienceCatherine H Miele, Kristin Schwab, Rajeev Saggar, et al.
JAMA|March 29, 2012
Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trialHarry P Selker, Joni R Beshansky, Patricia R Sheehan, et al.
The American Journal of Cardiology|May 6, 2014
One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care] Trial)Harry P Selker, James E Udelson, Joseph M Massaro, et al.
Journal of Medicinal Chemistry|October 26, 2025
Discovery of ORIC-533, an Orally Bioavailable CD73 Inhibitor That Maintains Activity in High AMP Environments to Reverse Tumor ImmunosuppressionJared T Moore, Hiroyuki Kawai, Brian R Blank, et al.
JCI Insight|November 8, 2022
NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomesDaniel R Calabrese, Tasha Tsao, Mélia Magnen, et al.
Brain : a Journal of Neurology|March 26, 2015
Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's diseaseCaroline Moreau, Sayah Meguig, Jean-Christophe Corvol, et al.
The European Respiratory Journal|July 9, 2026
Lung Transplantation for Pulmonary Alveolar Proteinosis - a Retrospective International Multi-Center AnalysisStefan Schwarz, Helmut Prosch, Erdal Yekeler, et al.
The Lancet Regional Health. Europe|June 26, 2021
Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational studyEric Van Belle, Thibault Manigold, Adeline Piérache, et al.
Pageof 53